Inve India ▾

Kaya share price & results

Kaya Ltd· Consumer Services· Consumer Discretionary

Results to
Jun 2026
Latest analysed call
Q1 FY26
Ownership as of
Sept 2026

India's leading dermatology-led clinic chain delivering skin, hair and body treatments, alongside a Kaya-branded skincare, haircare and nutraceuticals product range.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue60.0 ₹ crore+13.2% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin6.0 %−1.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-15.0 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity62.75 %+113.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Mar 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-7.66 %−2.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)2.29 %−3.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Mar 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

0 of 1 judged target kept · 4 open · verdicts reflect calls analysed to Q1 FY26.

Kaya Ltd management guidance track record on Inve: 5 targets tracked across analysed earnings calls (0 achieved, 1 missed, 4 open).

TargetOriginal wordingSaidLatest callVerdict
Clinic Renovation ProgramProgram will continue into FY26
Call transcript, Q4 FY25 · 29 May 2025		Q4 FY25Q1 FY26:No update provided on renovations; focus shifted entirely to new machines and new clinics.
Call transcript, Q1 FY26 · 6 Aug 2025		Ghosted
Annual Profitability ImprovementINR 18 crores annual improvement post rights issue (debt retirement)
Call transcript, Q4 FY25 · 29 May 2025		Q4 FY25Q1 FY26:Fundraising strategy shifted to preferential allotment first; rights issue delayed, pushing back debt retirement timeline.
Call transcript, Q1 FY26 · 6 Aug 2025		Delayed
New Clinic Additions7 clinics signed for FY26
Call transcript, Q4 FY25 · 29 May 2025		Q4 FY25Q1 FY26:Launched 2 in Q1, targeting 8 operational by Sep/Oct 2025.
Call transcript, Q1 FY26 · 6 Aug 2025		On Track

Source: Inve Guidance Tracker for Kaya Ltd · to Q1 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Kaya Ltd's 5 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 2 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹293.7 +4.59% · +₹12.9

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −32.5% 1Y

₹250₹300₹350₹400₹450Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹435 on 24 Oct 2025 → ₹293.7. High ₹459.55 (3 Nov 2025), low ₹227.1 (3 Jun 2026).

Previous close
₹280.8
Market cap
₹437 Cr
52-week range
₹227.1 – ₹459.55
One year
−31.70%
Return on equity (TTM to Mar 2026)
62.75%

Overview

Symbol
NSE:KAYA
Industry
Consumer Discretionary
Exchange
NSE
Currency
INR

What Kaya Ltd does

Based on the company's own presentations, annual report and earnings calls.

Kaya Limited runs a pan-India chain of dermatology clinics offering personalised skin, hair and body services such as anti-ageing treatment, acne and scar therapy, laser hair reduction, brightening and pigmentation treatment and body contouring, delivered by qualified dermatologists and beauty professionals. It also formulates and sells a Kaya-branded range of skin-care, hair-care and nutraceutical products (including the Kaya Nutra+ line) through its clinics. The company earns revenue from clinic service fees for treatments and from sale of its proprietary product portfolio.

Segments

  • Skin Care
  • Hair Care
  • Body Care
  • Nutraceuticals
Clinics
75+
Dermatologists
100+
Cities
25+
States
15
Product portfolio
75+
Cumulative clients served
35+ lakh (~3.5 million) beautified
Founded 2003Headquarters Mumbai, Maharashtra, India Company website

Your own record

Start an Inve Case for Kaya Ltd

Free account: one company. Everything above stays public.

Write why you follow Kaya Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Consumer Services companies

All Consumer Services companies → · Consumer Services earnings growth →

Learn to analyse Kaya Ltd

Guides on how to read this kind of business and the numbers that matter.